Tissue Repair & Regeneration
Palmitoyl Tripeptide-1

Last updated
Manufacturer’s claim vendor marketing
For a proprietary cosmetic ingredient the manufacturer is the originator — there is no upstream to defer to, and this is often the only description that exists. It is reproduced as an attributed claim, with the label its source gave it. It is not graded and it is not evidence — the graded studies are under Literature.
Vendor claims quoted from fetched page: stimulates "collagen production, promote[s] skin healing, and improve[s] the overall appearance of the skin"; "reduce the appearance of fine lines, wrinkles, and sagging skin". No n= or study duration given on fetched page.
- Manufacturer
- Croda (Sederma brand)
- Sold as
- Matrixyl 3000 (blend with Palmitoyl Tetrapeptide-7); also ActiTide 3000 (Uniproma), MAXI-LIP (distributed by Brenntag)
- Manufacturer’s recommended use
- Vendor claim: "typically 2% to 5%"
Source page — nofollow, because a vendor link is a reference here, not an endorsement.
Dosing on file unverified
4 ppm to 0.1% in creams, 1-2x/day
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 6
-
human observational
An Open-Label Study to Assess the Efficacy and Tolerability of a Multifunctional, 10-Peptide Face and Neck Serum to Address Skin Quality. graded on: indexed as a clinical trial, design not stated — “Clinical Trial”
-
human RCT
Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream. graded on: names a randomised controlled trial — the indexed publication type — “Randomized Controlled”
-
animal in vivo
Targeting Circadian Rhythm for the Regulation of Skin Collagen Metabolism. graded on: an animal model — read from the indexed abstract — “Mice”
Not graded
3 citations whose study design could not be read from the title. Left ungraded rather than guessed at.
- not graded
- not graded
- not graded
Identity
Skeletal formulathe canonical depiction
Drawn by PubChem from CID 10231864, the identifier on this record.
- Molecular weight
- 578.8
- Molecular formula
- C30H54N6O5
- CAS number
- 147732-56-7
- PubChem CID
- 10231864
- InChI key
- BYUQATUKPXLFLZ-UIOOFZCWSA-N
- SMILES
- CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCCN)C(=O)O
- InChI
- InChI=1S/C30H54N6O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-27(37)33-22-28(38)35-26(20-24-21-32-23-34-24)29(39)36-25(30(40)41)17-15-16-19-31/h21,23,25-26H,2-20,22,31H2,1H3,(H,32,34)(H,33,37)(H,35,38)(H,36,39)(H,40,41)/t25-,26-/m0/s1
Also called
- ActiTide 3000
- Matrixyl 3000
- Palmitoyl Tripeptide-1
Notes unverified prose
Clinical trial (n=30): nasolabial fold depth -36.35% at 8-12 weeks; Matrixyl 3000 blend (with tetrapeptide-7) has largest published human cosmetic dataset; Blind randomized clinical study (28 volunteers); Matrixyl 3000 blend
Not on file 1
1 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- amino-acid sequencenothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.